Merck, Moderna detail potential skin cancer vaccine progress

Dec 12, 2022, 3:16 PM | Updated: Dec 13, 2022, 8:09 am
FILE - A sign marks an entrance to a Moderna building in Cambridge, Mass., on Monday, May 18, 2020....

FILE - A sign marks an entrance to a Moderna building in Cambridge, Mass., on Monday, May 18, 2020. Shares of Merck and Moderna jumped early Tuesday, Dec. 13, 2022, after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots did well in a mid-stage study. (AP Photo/Bill Sikes, File)

(AP Photo/Bill Sikes, File)

Moderna’s stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a preventive shot for a deadly form of skin cancer.

The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in a small study of patients who had the cancer surgically removed.

The drugmakers said a combination of the vaccine and Merck’s immunotherapy Keytruda led to a statistically significant improvement in survival before the cancer returned in patients with advanced melanoma.

“We are very excited, we are moving very quickly with Merck onto phase 3 for this study,” Moderna CEO Stephane Bancel told CNBC Tuesday morning.

Phase 3 is generally the largest and most expensive stage of clinical research before regulators review a potential drug for approval.

Moderna developed one of the most popular vaccines used to protect patients against COVID-19, and the drugmaker brought in more than $3 billion from its Spikevax in this year’s third quarter.

But vaccine use has slowed, and Moderna depends on Spikevax for nearly all its revenue.

Like Spikevax, the potential skin cancer vaccine uses mRNA technology. It trains a patient’s immune system to recognize and respond specifically to mutations in the DNA of the patient’s tumor.

In a mid-stage clinical trial involving 157 patients, researchers compared the vaccine-Keytruda combination with Keytruda alone.

Keytruda, Merck’s top seller, primes the body’s immune system to detect and fight tumor cells. Regulators have approved it to treat several types of cancer.

The patient group that took the potential vaccine and Keytruda saw a 44% reduction in the risk of death or the cancer returning, the companies said.

The treatments continued for about a year in both groups unless the disease came back or side effects became too severe.

Merck and Moderna expect to start a phase 3 study next year, and the companies say they intend to expand their approach to other tumor types.

Merck and Moderna established an agreement to work together in 2016, and the companies plan to share costs and profits in their collaboration. Merck also paid Moderna $250 million.

Shares of Cambridge, Massachusetts-based Moderna Inc. soared 23% to top $200 in midday trading while broader indexes climbed. Kenilworth, New Jersey-based Merck & Co. climbed less than 1%.

___

Follow Tom Murphy on Twitter: https://twitter.com/thpmurphy

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

substation...
Associated Press

Puyallup man accused in substation vandalism is released from custody

A federal judge issued the order for Matthew Greenwood, 32, after renewed efforts by his attorney to get Greenwood into a drug-treatment facility.
21 hours ago
FILE - The sun dial near the Legislative Building is shown under cloudy skies, March 10, 2022, at t...
Associated Press

Democrats in Washington state choose Conrad as new leader

The Washington State Democratic Party has chosen Shasti Conrad, the former leader of King County Democrats, as its new chair.
21 hours ago
Hinman Glacier...
Associated Press

Washington’s Hinman Glacier gone after thousands of years

The largest glacier between the high peaks of Mount Rainier and Glacier Peak has melted away after a long battle with global warming.
21 hours ago
Pierce County substation...
Associated Press

Man accused in holiday substation vandalism released from custody

A man charged with vandalizing electrical substations over the holidays to cover a burglary was released from federal custody.
21 hours ago
Associated Press

Ex-UCLA lecturer accused of threats ruled mentally unfit

LOS ANGELES (AP) — A former lecturer at the University of California, Los Angeles accused of threatening students and staff was found mentally unfit to stand trial last week by a federal judge in Denver. U.S. District Court Judge Raymond P. Moore wrote in a Jan. 27 court filing that lawyers for Matthew Harris filed […]
21 hours ago
This photo provided by Peter Phung shows Phung, left, and Ming Wei Ma at the American Chinese Sprin...
Associated Press

Ballroom shooting victims planned for night of fun, dancing

LOS ANGELES (AP) — Those killed by a gunman who opened fire at a Los Angeles-area dance hall are being remembered by friends and family for the zest for life that brought them out that night to celebrate the Lunar New Year. Eleven people were killed when a gunman opened fire on Saturday night at […]
21 hours ago

Sponsored Articles

safety from crime...

As crime increases, our safety measures must too

It's easy to be accused of fearmongering regarding crime, but Seattle residents might have good reason to be concerned for their safety.
Comcast Ready for Business Fund...
Ilona Lohrey | President and CEO, GSBA

GSBA is closing the disparity gap with Ready for Business Fund

GSBA, Comcast, and other partners are working to address disparities in access to financial resources with the Ready for Business fund.
SHIBA WA...

Medicare open enrollment is here and SHIBA can help!

The SHIBA program – part of the Office of the Insurance Commissioner – is ready to help with your Medicare open enrollment decisions.
Lake Washington Windows...

Choosing Best Windows for Your Home

Lake Washington Windows and Doors is a local window dealer offering the exclusive Leak Armor installation.
Anacortes Christmas Tree...

Come one, come all! Food, Drink, and Coastal Christmas – Anacortes has it all!

Come celebrate Anacortes’ 11th annual Bier on the Pier! Bier on the Pier takes place on October 7th and 8th and features local ciders, food trucks and live music - not to mention the beautiful views of the Guemes Channel and backdrop of downtown Anacortes.
Swedish Cyberknife Treatment...

The revolutionary treatment of Swedish CyberKnife provides better quality of life for majority of patients

There are a wide variety of treatments options available for men with prostate cancer. One of the most technologically advanced treatment options in the Pacific Northwest is Stereotactic Body Radiation Therapy using the CyberKnife platform at Swedish Medical Center.
Merck, Moderna detail potential skin cancer vaccine progress